Therapeutic Asset Ratings

8,400 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Chimeric Antigen Receptor Modified T Cells Infusion Lymphoproliferative Disorders	UNC Lineberger Comprehensive Cancer Center	P1/2	CCC (52)
CIS-DIAMMINEDICHLOROPLATINUM II Haematologic Disease	Anaveon AG	P1/2	CCC (52)
Cobimetinib Pancreatic Adenocarcinoma	OHSU Knight Cancer Institute	P1/2	CCC (52)
ctx131 Malignant Pleural Mesothelioma	CRISPR Therapeutics AG	P1/2	CCC (52)
Cyclophosphamide Adenoid Cystic Carcinoma	Seagen, a wholly owned subsidiary of Pfizer	P1/2	CCC (52)
Cyclophosphamide Anal Squamous Cell Carcinoma	SCG Cell Therapy Pte. Ltd.	P1/2	CCC (52)
Cyclophosphamide Microsatellite Instability High	NextCure, Inc.	P1/2	CCC (52)
Cyclophosphamide Recurrent Primary Peritoneal Carcinosarcoma	Mayo Clinic	P1/2	CCC (52)
Cyclophosphamide Relapsed Adult AML	Masonic Cancer Center, University of Minnesota	P1/2	CCC (52)
Cyclophosphamide Uterine Cancer	Genmab	P1/2	CCC (52)
Cypep-1 Head And Neck Squamous Cell Carcinoma	Cytovation AS	P1/2	CCC (52)
DARATUMUMAB Hematologic Disorder	Anaveon AG	P1/2	CCC (52)
Dasatinib Metabolic Dysfunction-Associated Steatohepatitis	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	P1/2	CCC (52)
Decitabine Acute Lymphoblastic Leukemia	Princess Maxima Center for Pediatric Oncology	P1/2	CCC (52)
Decitabine Fallopian Tube Carcinoma	Roswell Park Cancer Institute	P1/2	CCC (52)
Decitabine Melanoma	University of Colorado, Denver	P1/2	CCC (52)
Decitabine Prostate Cancer	Roswell Park Cancer Institute	P1/2	CCC (52)
DISODIUM 4-((TERT-BUTYLIMINO)METHYL)BENZENE-1,3-DISULFONATE N-OXIDE Astrocytic Tumor	Oblato, Inc.	P1/2	CCC (52)
DISODIUM 4-((TERT-BUTYLIMINO)METHYL)BENZENE-1,3-DISULFONATE N-OXIDE Oligodendroglioma	Oblato, Inc.	P1/2	CCC (52)
Docetaxel Gastroesophageal Adenocarcinoma	Laekna Limited	P1/2	CCC (52)
DPC-A69448 Male	Hangzhou Gensciences Biopharmaceutical Co., Ltd.	P1/2	CCC (52)
Droxidopa Menkes Disease	Stephen G. Kaler	P1/2	CCC (52)
Duvelisib T-Cell Prolymphocytic Leukemia	Jonsson Comprehensive Cancer Center	P1/2	CCC (52)
e-602 Gastroesophageal Junction Adenocarcinoma	Palleon Pharmaceuticals, Inc.	P1/2	CCC (52)
Edetate Calcium Disodium Myelodysplastic/Myeloproliferative Neoplasm	M.D. Anderson Cancer Center	P1/2	CCC (52)

Showing 526 to 550 of 8,400 assets

PreviousPage 22 of 336Next